Summary
RENEURON, the Guildford-based stem cell research company, has announced widening financial losses, but it also said that patient recruitment for trials at the Southern General Hospital in Glasgow are now under way.
It emerged last year that Glasgow was to become the centre for the research into the effectiveness of transplanting stem cells made from human foetal tissue into the brains of stroke patients.See the full content of this document
Extract
Stem Cell Research Firm Sees Widening Losses
Nonetheless, ReNeuron posted a pre-tax l...
See the full content of this document
Sponsored links
